Cargando…
Management of Hypertriglyceridemia in the Diabetic Patient
The hypertriglyceridemia of diabetes can be classified into mild to moderate (triglycerides between 150–499 mg/dL) and severe hypertriglyceridemia (triglycerides ≥500 mg/dL). As in any other individuals with hypertriglyceridemia, secondary causes need to be excluded. The management of severe hypertr...
Autores principales: | Jialal, Ishwarlal, Amess, William, Kaur, Manpreet |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890983/ https://www.ncbi.nlm.nih.gov/pubmed/20532703 http://dx.doi.org/10.1007/s11892-010-0124-4 |
Ejemplares similares
-
Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019) -
Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014) -
Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014) -
Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016) -
SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome
por: Ramakrishnan, Neeraj, et al.
Publicado: (2020)